Search Browse Earnings

KYNTRA BIO, INC. — SlamSEC

KYNTRA BIO, INC.

Nasdaq:KYNB

Pharmaceutical Preparations·SAN FRANCISCO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Kyntra Bio, Inc. is a biopharmaceutical company headquartered in San Francisco, California.

Revenue

$46.8M

-80.1% YoY

FY 2024

Adj. EBITDA

-$313.2M

-669.2% margin

FY 2024

Net Income

-$284.2M

-607.3% margin

FY 2024

EPS (Diluted)

-$2.92

FY 2024

Stock Price

$6.97

-2.1%

2026-03-13

52W Range

$4.85 – $12.60

P/E Ratio

-2.4x

Market Cap

$28.2M

Cash

$81.6M

FY 2024

Total Debt

—

Net Cash

$81.6M

FY 2024

Enterprise Value

-$53.4M

Debt / EBITDA

0.3x

FY 2024

EV / EBITDA

0.2x

Employees

—